Ngomhla wama-28 kuFebruwari, ngo-2026, i-National Medical Products Administration (NMPA) yavuma ngokusesikweni ukuthengiswa kwe-JMKX001899 sulfate kunyango lwabantu abadala abane-KRAS G12C-mutated advanced non-small cell lung cancer (NSCLC) abaye bafumana ubuncinane unyango olunye lwangaphambili.
I-JMKX001899 sisithinteli se-KRAS G12C esikhethwa kakhulu kwaye ngaphambili sifumene igama elithi "Breakthrough Therapy" kwi-NMPA.
Iinkcukacha eziphambili zeklinikhi ziyakhuthaza:
- Izinga lokuphendula ngendlela echanekileyo (ORR) lifikelele phezulu kwi-55.2%
- Izinga lokusinda lilonke leenyanga ezili-12 (OS) lifikelele kuma-60.4%
Ukongeza kwidatha ebalaseleyo yenzuzo yokusinda, i-JMKX001899 ikwafezekisa ukuphuculwa okukhulu kumava amayeza esigulana, yamkela inkqubo elula yokunika idosi "kanye ngemini, iipilisi ezimbini ngexesha ngalinye," kunye nokunyamezeleka okuhle, ngaloo ndlela iphucula ukuthobela kwesigulana amayeza exesha elide.
Okwangoku, izifundo zonyango zale chiza ziyaqhubeka nakwizigulane ezineethumba eziqinileyo ezifana nomhlaza we-colorectal ogcina utshintsho lwe-KRAS G12C, ezinokuthi zincede iintlobo ezininzi zezigulane ezinomhlaza kwixesha elizayo.
**Kutheni ukhetha iSebe leMicimbi yeHlabathi leSibhedlele se-Oncology saseBeijing South Region?**
- **Ubuchwephesha bezonyango obuphambili:** Sihlala sinolwazi ngenkqubela phambili yamva nje kunyango lwe-oncology kwaye siphakathi kwabokuqala ukwazisa amayeza kunye nonyango olutsha, kuquka i-JMKX001899.
- **Iqela leeNgcali eziNxulumene neMicimbi eMininzi:** Iqela lethu lokubonisana nemibutho eyahlukeneyo liquka iingcali ezinamava ze-oncology, iingcali ze-radiology, kunye neengcali zezifo eziphuhlisa izicwangciso zonyango ezenzelwe umntu ngamnye.
- **Inkonzo Yokumisa Kanye:** Ukususela kwingxoxo yokuqala kunye novavanyo lwemfuza ukuya kuphuhliso lwesicwangciso sonyango, isikhokelo samayeza, kunye nolawulo lokulandelela, sinikezela ngeenkonzo zonyango ezingenamthungo, eziphuma ngokupheleleyo.
- **Indawo Yonyango Yamazwe Ngamazwe:** Sixhotyiswe ngezibonelelo zonyango eziphambili, sakha indawo yokuphilisa efudumeleyo nekhululekileyo kwaye sihlonipha iimfuno ezithile zezigulana ezivela kwiinkcubeko ezahlukeneyo.
- **Iinkonzo zeNkxaso yoLwimi:** Sinikezela ngeenkonzo zokuguqulela iilwimi ezininzi ukuze kususwe imiqobo yonxibelelwano kwaye kuqinisekiswe unxibelelwano oluchanekileyo phakathi koogqirha nezigulana.
**Nxibelelana Nathi Ngoku ukuze ufumane Iindlela Zonyango Eziphambili**
Ukuba wena okanye umntu omthandayo ujongene nomceli mngeni womhlaza wemiphunga ongengoweseli encinci oguqulwe yi-KRAS G12C, nceda uzive ukhululekile ukuqhagamshelana neSibhedlele se-Oncology seSebe leMicimbi yeHlabathi saseBeijing South Region. Iqela lethu leengcali liza kukunika iingcebiso zonyango ezineenkcukacha kunye noncedo lokufuna unyango eTshayina.
- Ingxoxo ngefowuni: 400-880-3716
- Ingcebiso yeWeChat: 17801183037
- I-imeyile:
- 100085_010@163.com
- myimmnet@163.com
**Imibuzo ebuzwa qho**
**U: Izigulane zamazwe ngamazwe zingazicwangcisa njani iinkonzo zonyango kwiSebe leMicimbi yeZibhedlele ze-Oncology zaseBeijing South Region?**
**Impendulo:** Ungaqhagamshelana nathi ngefowuni, iWeChat, okanye i-imeyile. Abaququzeleli bethu bezigulane bamazwe ngamazwe baya kukukhokela kwinkqubo yokuqeshwa, kubandakanya ukuhanjiswa kweerekhodi zonyango, amalungiselelo okubonisana kude, kunye noncedo lwe-visa yokuya eTshayina.
**U: Zithini iindleko zezigulana zamazwe ngamazwe ezifumana unyango eTshayina?**
**Impendulo:** Iindleko zonyango ziyahluka ngokuxhomekeke kwiimeko zomntu ngamnye, kuquka nenkqubo yamayeza kunye nobude bonyango. Emva kokunxibelelana nathi, siza kunika uqikelelo oluneenkcukacha lweendleko olusekelwe kwimeko yakho ethile.
**U: Ingaba isibhedlele sinikezela ngeenkonzo zokubonisana nabantu bekude?**
**Impendulo:** Ewe, sinikezela ngeenkonzo zokubonisana ngevidiyo ezikude kwizigulane zamazwe ngamazwe, oku kukuvumela ukuba ube nengxoxo yokuqala neqela lethu leengcali ngaphambi kokuba uye eTshayina ukuze uqonde isicwangciso sonyango kunye neziphumo ezilindelekileyo.
Ixesha lokuthumela: Matshi-04-2026